+ Bookmark This Page    
Preferences  |  6:10 AM
  1. Home
  2. Latest Press Releases
  3. Submit Press Releases
  1. PR Home
  2. News Archive
  3. By Category
  4. By Location
  5. By Date
  6. By Tag
  7. Newsletter
  8. 40,000 RSS Feeds
  9. Submit Free Press Release
   
Filter News
Show All Results

Show Filtered Results

Category
(To see all categories,
remove other filters)


Country
- United States (x)

State / Province

City / Town
Select State First

Dr. Reddy's Pharmaceutical Company Commences Operations in Philippines.

Dr. Reddy's Pharmaceutical Company Commences Operations in Philippines. Expands presence in the ASEAN region
 

 
Pharmaceutical Company

Pharmaceutical Company

FOR IMMEDIATE RELEASE

PRLog (Press Release)Oct 10, 2007 – Dr.Reddy’s pharmaceutical company(http://www.drreddys.com/) has expanded its presence in the ASEAN region with the opening of its 41st overseas office in Manila, Philippines in partnership with Britton Marketing Corporation, a sister company of Britton Distributions, Inc. This distributor-based model will serve the US $1.8 billion Philippines pharmaceutical market, which is growing at over 10% annually.

The pharmaceutical company is initially targeting therapeutic areas like cardiology, diabetology, gastroenterology and pain management. The first phase of launch will see major brands like Omez(Omeprazole), Stamlo M(Amlodipine maleate), Resilo (Losartan) ,Reclide(Gliclazide), Cardiopril(Ramipril), Rafree(Meloxicam), Ciprolet(Ciprofloxacin), and Finast(Finasteride) being introduced in the Philippines market.

Commenting on the opening of the new office, Rajesh Kumar, Head- AMEEERA region said,
“Accessibility of quality and affordable medicines is among the pressing issues in Philippines today. It is one of the key markets in the ASEAN region for us and being a leader in the generics space, Dr. Reddy’s has a lot to offer to the Filipino medical community and the people of Philippines. BMC has a strong marketing presence in the healthcare products market and together with Dr. Reddy’s, is ideally placed to serve this market”.

Notes to the editor:
The Branded Pharmaceutical Formulations(http://www.drreddys.com/bdivisions/brandedformulations.htm) Business of Dr Reddy’s operates from six geographic regions: India & SAARC, Russia & CIS countries, China, Latin America, South Africa & AMEERA (Asean Middle East Eastern Europe Rest of Africa)
In ASEAN, Dr. Reddy’s already has presence in Myanmar, Vietnam, Cambodia, Malaysia, Singapore, and Thailand
http://www.drreddys.com

Contact Information:
Investors and Financial Analysts:
Nikhil Shah at nikhilshah@drreddys.com or on +91-40-23731946 ext. 308
Media:
M Mythili at mythilim@drreddys.com or on +91-40-66511620

# # #

Dr. Reddy's Laboratories (NYSE: RDY) is an emerging global pharmaceutical company established in 1984, with proven research capabilities. The Company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products (http://www.drreddys.com/bdivisions/bio_products.htm) and markets them globally, with focus on India, US, Europe and Russia.


To embed this press release, copy and paste the following HTML code into your webpage-
# # # Click to see PDF Version of this Press Release

Email to a Friend       Previous News   Next News


Issued By:Dr.Reddy's Pharmaceutical Company
Website:http://www.drreddys.com/
Email Contact:Click to email
Phone:+91-40-66511620
Fax:+91-40-23731955
Address:Dr.Reddy's Laboratories Ltd
:Greenlands, Ameerpet,
City/Town:Hyderabad
State/Province:Andhra Pradesh
Zip:500 016
Country:India
Categories:Medical, Biotech, Business
Tags:pharmaceutical company, pharmaceutical research, active pharmaceutical ingredients, biotechnology products
Shortcut:http://prlog.org/10033744

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog.Org can't be held liable for the contents of the press releases.   Report Abuse


Upcoming Press Releases...


Related?

Dr. Reddy's Pharmaceutical Company to release Q2 FY08 results on October 24, 2007

Dr.Reddy’s Pharmaceutical Company Q2 FY08 revenue at Rs 12,670 million

Dr. Reddy'S Pharmaceutical Company Annual Report on form 20-F for year ended March 31, 2007

Dr. Reddys receives USFDA approval for Ranitidine (Zantac™) Tablets, 150mg (OTC)

42 market research launches Online Interviews for Pharmaceutical Research in Brazil and Mexico


Most Viewed Weekly

Responding to H1N1 Flu-like Symptoms and H1N1 Flu Prevention - 6752 views

Movie about Sirius XM Radio Gets Worldwide Distribution Deal - 2338 views

Sprint Nextel Corporation faces long term shareholder investigation - 1724 views

Apollo Group, Inc. faces shareholder investigation - 1190 views

Service Records Of Two Million First World War British Soldiers Now Online - 1154 views


Daily News!

Manufacturing Journalist TR Cutler Devises Coaching Systems for Manufacturers

Diabetes Congress opens in Dubai

Sustainable Construction Services and ZeroEnergy Design Win Gold CotY Award

Emirates Computers to equip BMW’s New Showroom with Cutting Edge Technologies

Detroit Band Helps Raise Funds For Charity

Previous   Next

Oct 10, 2007 News

Oct 2007 News

Are you a Journalist?

For Businesses ...

Tutorial on Free Marketing


November 2009
Su Sa Fr Th We Tu Mo
8 7 6 5 4 3 2
1
October 2009
31 30 29 28 27 26
25 24 23 22 21 20 19
18 17 16 15 14 13 12



  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Use
  5. Copyright Notice